JP2008535774A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008535774A5 JP2008535774A5 JP2007547675A JP2007547675A JP2008535774A5 JP 2008535774 A5 JP2008535774 A5 JP 2008535774A5 JP 2007547675 A JP2007547675 A JP 2007547675A JP 2007547675 A JP2007547675 A JP 2007547675A JP 2008535774 A5 JP2008535774 A5 JP 2008535774A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- prostaglandin
- compound
- alkyl
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 24
- -1 prostaglandin compound Chemical class 0.000 claims 19
- 125000000217 alkyl group Chemical group 0.000 claims 13
- 150000003839 salts Chemical class 0.000 claims 10
- 125000003545 alkoxy group Chemical group 0.000 claims 9
- 229910052736 halogen Inorganic materials 0.000 claims 9
- 150000002367 halogens Chemical class 0.000 claims 9
- 229910052739 hydrogen Inorganic materials 0.000 claims 9
- 239000001257 hydrogen Substances 0.000 claims 9
- 150000002431 hydrogen Chemical class 0.000 claims 8
- 229940121819 ATPase inhibitor Drugs 0.000 claims 7
- 239000000362 adenosine triphosphatase inhibitor Substances 0.000 claims 7
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 6
- 125000000623 heterocyclic group Chemical group 0.000 claims 5
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 claims 4
- 229960003174 lansoprazole Drugs 0.000 claims 4
- MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 claims 4
- 229960000381 omeprazole Drugs 0.000 claims 4
- 125000004423 acyloxy group Chemical group 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- 125000004043 oxo group Chemical group O=* 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims 2
- 150000001447 alkali salts Chemical class 0.000 claims 2
- 125000004104 aryloxy group Chemical group 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 229960004770 esomeprazole Drugs 0.000 claims 2
- SUBDBMMJDZJVOS-DEOSSOPVSA-N esomeprazole Chemical compound C([S@](=O)C1=NC2=CC=C(C=C2N1)OC)C1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-DEOSSOPVSA-N 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 2
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 150000003180 prostaglandins Chemical class 0.000 claims 2
- 229920006395 saturated elastomer Polymers 0.000 claims 2
- 208000023514 Barrett esophagus Diseases 0.000 claims 1
- 208000023665 Barrett oesophagus Diseases 0.000 claims 1
- 206010063655 Erosive oesophagitis Diseases 0.000 claims 1
- 208000007882 Gastritis Diseases 0.000 claims 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 claims 1
- 206010019375 Helicobacter infections Diseases 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 206010030201 Oesophageal ulcer Diseases 0.000 claims 1
- IQPSEEYGBUAQFF-UHFFFAOYSA-N Pantoprazole Chemical compound COC1=CC=NC(CS(=O)C=2NC3=CC=C(OC(F)F)C=C3N=2)=C1OC IQPSEEYGBUAQFF-UHFFFAOYSA-N 0.000 claims 1
- 208000008469 Peptic Ulcer Diseases 0.000 claims 1
- 208000007107 Stomach Ulcer Diseases 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 208000025865 Ulcer Diseases 0.000 claims 1
- 206010061577 Ulcer haemorrhage Diseases 0.000 claims 1
- 201000008629 Zollinger-Ellison syndrome Diseases 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 125000005083 alkoxyalkoxy group Chemical group 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 150000001721 carbon Chemical group 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 229940111134 coxibs Drugs 0.000 claims 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 claims 1
- 125000004663 dialkyl amino group Chemical group 0.000 claims 1
- 208000000718 duodenal ulcer Diseases 0.000 claims 1
- 201000006549 dyspepsia Diseases 0.000 claims 1
- 208000028299 esophageal disease Diseases 0.000 claims 1
- 208000019064 esophageal ulcer Diseases 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 201000005917 gastric ulcer Diseases 0.000 claims 1
- 201000000052 gastrinoma Diseases 0.000 claims 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 claims 1
- 208000030304 gastrointestinal bleeding Diseases 0.000 claims 1
- 125000004438 haloalkoxy group Chemical group 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- PQIOSYKVBBWRRI-UHFFFAOYSA-N methylphosphonyl difluoride Chemical group CP(F)(F)=O PQIOSYKVBBWRRI-UHFFFAOYSA-N 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 125000005968 oxazolinyl group Chemical group 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 229960005019 pantoprazole Drugs 0.000 claims 1
- 208000011906 peptic ulcer disease Diseases 0.000 claims 1
- 125000002071 phenylalkoxy group Chemical group 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- YREYEVIYCVEVJK-UHFFFAOYSA-N rabeprazole Chemical compound COCCCOC1=CC=NC(CS(=O)C=2NC3=CC=CC=C3N=2)=C1C YREYEVIYCVEVJK-UHFFFAOYSA-N 0.000 claims 1
- 229960004157 rabeprazole Drugs 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 229910052717 sulfur Chemical group 0.000 claims 1
- 239000011593 sulfur Chemical group 0.000 claims 1
- 238000011282 treatment Methods 0.000 claims 1
- 125000004950 trifluoroalkyl group Chemical group 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- 231100000397 ulcer Toxicity 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67023805P | 2005-04-12 | 2005-04-12 | |
| US60/670,238 | 2005-04-12 | ||
| PCT/JP2006/308001 WO2006109881A1 (en) | 2005-04-12 | 2006-04-11 | Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013012487A Division JP2013121972A (ja) | 2005-04-12 | 2013-01-25 | 胃腸障害の処置のためのプロスタグランジン化合物およびプロトンポンプ阻害剤の併用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008535774A JP2008535774A (ja) | 2008-09-04 |
| JP2008535774A5 true JP2008535774A5 (enExample) | 2009-05-28 |
| JP5711442B2 JP5711442B2 (ja) | 2015-04-30 |
Family
ID=36685683
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007547675A Expired - Fee Related JP5711442B2 (ja) | 2005-04-12 | 2006-04-11 | 胃腸障害の処置のためのプロスタグランジン化合物およびプロトンポンプ阻害剤の併用 |
| JP2013012487A Pending JP2013121972A (ja) | 2005-04-12 | 2013-01-25 | 胃腸障害の処置のためのプロスタグランジン化合物およびプロトンポンプ阻害剤の併用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013012487A Pending JP2013121972A (ja) | 2005-04-12 | 2013-01-25 | 胃腸障害の処置のためのプロスタグランジン化合物およびプロトンポンプ阻害剤の併用 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8962688B2 (enExample) |
| EP (1) | EP1871380B1 (enExample) |
| JP (2) | JP5711442B2 (enExample) |
| KR (2) | KR20140069182A (enExample) |
| CN (1) | CN101198334B (enExample) |
| AU (1) | AU2006234632B2 (enExample) |
| BR (1) | BRPI0610557A2 (enExample) |
| CA (1) | CA2602812C (enExample) |
| DK (1) | DK1871380T3 (enExample) |
| ES (1) | ES2371658T3 (enExample) |
| IL (1) | IL186374A (enExample) |
| NO (1) | NO20075764L (enExample) |
| NZ (1) | NZ562763A (enExample) |
| PL (1) | PL1871380T3 (enExample) |
| PT (1) | PT1871380E (enExample) |
| RU (1) | RU2468800C2 (enExample) |
| WO (1) | WO2006109881A1 (enExample) |
| ZA (1) | ZA200709072B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8114911B2 (en) * | 2002-10-23 | 2012-02-14 | Sucampo Ag | Prostaglandin compounds for the treatment of obesity |
| US7868045B2 (en) * | 2006-09-06 | 2011-01-11 | Sucampo Ag | Method for promoting gastrointestinal bicarbonate secretion |
| US20090012165A1 (en) * | 2007-07-03 | 2009-01-08 | Sucampo Ag | Pharmaceutical combination of nsaid and prostaglandin compound |
| WO2009157397A1 (ja) * | 2008-06-23 | 2009-12-30 | 日本新薬株式会社 | 非ステロイド性抗炎症剤投与に伴う腸管傷害治療剤 |
| US20110034424A1 (en) * | 2009-06-30 | 2011-02-10 | Sucampo Ag | Method for the long term nsaid use |
| RU2013151166A (ru) * | 2011-04-19 | 2015-05-27 | Сукампо Аг | Способ модуляции активности цитокинов |
| WO2014159679A1 (en) | 2013-03-12 | 2014-10-02 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Methods for using lubiprostone to absorb fluid from the subretinal space |
| KR20160015100A (ko) | 2014-07-30 | 2016-02-12 | 미래파인켐 주식회사 | 프로스타글란딘 중간체의 제조방법 |
| KR20170025682A (ko) | 2015-08-31 | 2017-03-08 | 미래파인켐 주식회사 | 프로스타글란딘 유도체의 신규한 제조방법 |
| CN107582556A (zh) * | 2017-09-15 | 2018-01-16 | 成都泠汐尚品科技有限公司 | 一种治疗消化性溃疡的药物复方制剂 |
| CN108051553A (zh) * | 2017-12-29 | 2018-05-18 | 武汉轻工大学 | 一种仔猪肠道功能保护剂的筛选方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5428062A (en) | 1987-01-28 | 1995-06-27 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti ulcers containing same |
| US5166174A (en) | 1987-01-28 | 1992-11-24 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti-ulcers containing same |
| JPH0688966B2 (ja) * | 1987-01-28 | 1994-11-09 | 株式会社アールテック・ウエノ | プロスタグランジンｅ類およびそれを含む抗潰瘍剤 |
| US5225439A (en) | 1987-01-28 | 1993-07-06 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti ulcers containing same |
| CA1322749C (en) | 1987-01-28 | 1993-10-05 | Ryuzo Ueno | Prostaglandins of the d series, and tranquilizers and soporifics containing the same |
| US5221763A (en) | 1987-04-30 | 1993-06-22 | R-Tech Ueno, Ltd. | Prostaglandins of the F series |
| US5317032A (en) | 1987-10-02 | 1994-05-31 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Prostaglandin cathartic |
| CA2039420C (en) | 1990-04-04 | 1996-12-10 | Ryuji Ueno | Treatment of cataract with 15-keto-prostaglandin compounds |
| CA2150287C (en) | 1994-06-03 | 2004-08-10 | Ryuji Ueno | Agent for treating hepato-biliary diseases |
| DK0857718T3 (da) | 1996-06-10 | 2002-12-16 | Sucampo Ag | Endothelinantagonist |
| SE9804314D0 (sv) * | 1998-12-14 | 1998-12-14 | Astra Ab | New pharmaceutical formulation |
| PT1220849E (pt) | 1999-10-15 | 2004-10-29 | Sucampo Ag | Composicao de compostos biciclicos e metodo para a sua estabilizacao |
| DE60139002D1 (de) * | 2000-04-06 | 2009-07-30 | Sucampo Ag | Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält |
| US6414016B1 (en) | 2000-09-05 | 2002-07-02 | Sucampo, A.G. | Anti-constipation composition |
| TWI302100B (en) * | 2001-05-02 | 2008-10-21 | Sucampo Ag | Composition for treating drug-induced constipation |
| MXPA04002006A (es) | 2001-08-31 | 2004-06-07 | Sucampo Ag | Analogos de prostagladina como abridor del canal de cloruro. |
| AR037524A1 (es) | 2001-11-14 | 2004-11-17 | Sucampo Ag | Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion |
| US7732487B2 (en) | 2001-11-19 | 2010-06-08 | Sucampo Ag | Method for treating a disease or condition responsive to opening of C1C-2 channel |
| ES2591252T3 (es) * | 2002-12-27 | 2016-11-25 | Sucampo Ag | Derivados de prostaglandinas para tratar el síndrome de colon irritable y/o la dispepsia funcional |
| US9060959B2 (en) * | 2003-01-24 | 2015-06-23 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) | Synergistic compositions and method for potentiating anti-oxidative activity |
| CA2517005A1 (en) * | 2003-02-20 | 2004-09-02 | Santarus, Inc. | A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
-
2006
- 2006-04-11 CN CN200680021015XA patent/CN101198334B/zh active Active
- 2006-04-11 RU RU2007141655/15A patent/RU2468800C2/ru not_active IP Right Cessation
- 2006-04-11 WO PCT/JP2006/308001 patent/WO2006109881A1/en not_active Ceased
- 2006-04-11 DK DK06731937.6T patent/DK1871380T3/da active
- 2006-04-11 ES ES06731937T patent/ES2371658T3/es active Active
- 2006-04-11 JP JP2007547675A patent/JP5711442B2/ja not_active Expired - Fee Related
- 2006-04-11 AU AU2006234632A patent/AU2006234632B2/en active Active
- 2006-04-11 US US11/401,382 patent/US8962688B2/en not_active Expired - Fee Related
- 2006-04-11 BR BRPI0610557-2A patent/BRPI0610557A2/pt not_active IP Right Cessation
- 2006-04-11 PL PL06731937T patent/PL1871380T3/pl unknown
- 2006-04-11 NZ NZ562763A patent/NZ562763A/en not_active IP Right Cessation
- 2006-04-11 PT PT06731937T patent/PT1871380E/pt unknown
- 2006-04-11 KR KR1020147010338A patent/KR20140069182A/ko not_active Ceased
- 2006-04-11 CA CA2602812A patent/CA2602812C/en not_active Expired - Fee Related
- 2006-04-11 EP EP06731937A patent/EP1871380B1/en not_active Not-in-force
-
2007
- 2007-10-07 IL IL186374A patent/IL186374A/en not_active IP Right Cessation
- 2007-10-22 ZA ZA200709072A patent/ZA200709072B/xx unknown
- 2007-11-09 NO NO20075764A patent/NO20075764L/no not_active Application Discontinuation
- 2007-11-12 KR KR1020077026266A patent/KR101466980B1/ko not_active Expired - Fee Related
-
2013
- 2013-01-25 JP JP2013012487A patent/JP2013121972A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008535774A5 (enExample) | ||
| ME01598B (me) | Jedinjenja pirola | |
| JP2005521642A5 (enExample) | ||
| MX2009000080A (es) | Derivados de bencimidazol como inhibidores selectivos de la bomba de acido. | |
| TW200732326A (en) | Chromane substituted benzimidazole derivatives | |
| JP2007531744A5 (enExample) | ||
| KR101466980B1 (ko) | 위장 장애 치료를 위한 프로스타글란딘 화합물과 양성자펌프 억제제의 병용 | |
| JP2006527776A5 (enExample) | ||
| FI4148050T3 (fi) | Uusi haponerityksen estäjä ja sen käyttö | |
| JP2012501296A5 (enExample) | ||
| CA2686545A1 (en) | Deuterated morpholinyl compounds | |
| JP2009521931A5 (enExample) | ||
| JP2004501930A5 (enExample) | ||
| JP2005539013A5 (enExample) | ||
| JP2010155827A5 (enExample) | ||
| RU2011123672A (ru) | Гетероароматические соединения для применения в качестве hif ингибиторов | |
| JP2003512327A5 (enExample) | ||
| ME01855B (me) | Jedinjenja benzimidazola | |
| JP2009501745A5 (enExample) | ||
| ATE442140T1 (de) | Chroman-substituierte benzimidazolderivate als säurepumpenantagonisten | |
| JP2019526593A5 (enExample) | ||
| NO20072764L (no) | Kromanderivater som er nyttige syrepumpeantagonister | |
| JP6231195B2 (ja) | スルホニルインドール誘導体およびその製造方法 | |
| AR059903A1 (es) | Derivados de cromano | |
| RU2007121842A (ru) | Сульфамиды в качестве антагонистов эндотелинового рецептора, предназначенные для лечения сердечно-сосудистых заболеваний |